Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Transplant Diagnostics Market Size & Trends

The global transplant diagnostics market size was valued at USD 5.97 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2030. The demand for transplant diagnostics is expected to grow owing to factors such as increasing geriatric population, prevalence of chronic disease and advancements in transplantation procedures.

As chronic diseases like heart failure, kidney diseases, and liver disorders are on the rise, the need for organ transplantation as a life-saving treatment is also increasing. This increase in transplantation process highlights the importance of accurate and advanced diagnostic tools to ensure that donors and recipients are compatible, reducing the risk of organ failure and improving the success rates of transplantation.

Consequently, the market is driven by the rising incidence of organ, leading to the continuous development of innovative transplant diagnostic technologies and improved medical devices to meet the growing hospitals & specialized clinical demand and ultimately enhance patient outcomes.

Test Insights

In 2023, the molecular assays segment dominated the market and accounted for largest revenue share of 41.5%. Molecular assays offer more features compared to non-molecular assays, it is a more sensitive method allowing detection of lower amounts of infectious agents and it tends to be accurate. Furthermore, molecular assays are widely used in pre-surgical diagnostics procedures for testing the compatibility of donor and a recipient.

The sequencing-based molecular assays are expected to witness the fastest CAGR of 8.3% during the forecast period. The current research and development in transplant diagnostics prioritize more accurate and highly sensitive tests. This focus on improved diagnostics has the potential to enhance the patient outcomes and drive the future demand for sequencing based molecular assays.

Product Insights

In 2023, the reagents and consumables segment dominated the market and accounted for largest revenue share in 2023, owing to the growing demand for effective and early profiling during organ transportation.

The software and services segment is expected to witness the fastest CAGR during the forecast period, owing to the latest developments in the software industry and improved services offered by the market players. Moreover, the recent development in software technology and with the induction of Artificial Intelligence (AI) and Machine Learning (ML) are giving more efficient output.

Application Insights

Diagnostics dominated the market and accounted for the largest market revenue share of 71.1% in 2023. Research application on the other hand, is expected to witness a significant growth during the forecast period.  

Diagnostics enables matching recipient and organ donor by evaluating compatibility primarily via Human Leukocyte Antigen (HLA) testing. Transplant diagnostics includes screening of both recipients & donors for viral infections ensuring that infections are detected before transplantation to prevent their transmission.

Transplant Area Insights

The solid organ transplantation segment dominated the market in 2023 and accounted for a revenue share of 45.5% in 2023, owing to the rising cardiovascular, liver and lung diseases across the globe.

Stem cell transplantation is expected to witness the fastest CAGR during the forecast period. Stem cells are used in several treatments like treatment of cardiovascular and autoimmune diseases.

End Use Insights

Hospitals and transplant centers dominated the market with a revenue of 2.72 billion in 2023, owing to the rising healthcare expenditure and use of advanced medical devices in these settings. Hospitals are the integral components of the organ transplantation process. In addition, several countries are focusing more on the development of hospitals and specialized centers that focus on organ transplantation.

Research and academic institutes are expected to witness the fastest CAGR during the forecast period. Government and private institutes are focusing more on efficient solutions for organ transplantation and diagnostics. Moreover, the HRSA, an agency of the U.S. Government, in March 2023, announced organ procurement and transplantation network modernization initiative to strengthen accountability and transparency in organ procurement and transplantation network (OPTN).

Regional Insights

In 2023, the North America transplant diagnostics market held a considerable market share of 33.0%, owing to the availability of well-developed health infrastructure and a high adoption of advanced medical technologies. Furthermore, a rise in investment in research and development for organ transplantation is driving the market. According to Health Resource & Service Administration (HRSA), as of March 2024, more than 46,000 organ transplants were performed in U.S.

U.S Transplant Diagnostics Market Trends

In 2023, the transplant diagnostics market in the U.S. captured a significant market share, owing to advanced healthcare infrastructure, advanced medical technology & devices and rising awareness among citizens about organ transplantation.

Europe Transplant Diagnostics Market Trends

The Europe transplant diagnostics market held a significant market share in 2023. This growth is attributed to a rise in healthcare budget and availability of professional surgeons and well-equipped advanced healthcare technologies in the region.

The UK transplant diagnostics market held the largest market share in Europe, owing to availability of skilled surgeons, growing healthcare expenditure, and highly developed healthcare infrastructure.

Germany transplant diagnostics market is expected to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure and adoption of advanced medical devices.

Asia Pacific Transplant Diagnostics Market Trends

The transplant diagnostics market in Asia Pacific is projected to witness the fastest CAGR of 10.12% during the forecast period. The growth is driven by advancements in healthcare infrastructure, increasing healthcare expenditure and rising disposable income. Also, there has been significant increase in prevalence of chronic disease in middle age and geriatric population especially in countries such as China, Japan and India.

The China transplant diagnostics market held the largest market share in 2023 owing to the improved healthcare professionals and infrastructure and awareness among public about importance of organ transplant.

Key Transplant Diagnostics Company Insights

The global market is highly competitive with players competing in the international market.

Some of the key companies in the transplant diagnostics market include Thermo Fisher Scientific, Inc.; Abbott; QIAGEN; Bruker, and others. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

QIAGEN N.V.: QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company’s key product areas include Digital PCR* (dPCR), Tuberculosis (TB) testing, Sample preparation and others. The company delivers a wide range of diagnostics products such as RNeasy Kits, QIAcube Connect., among others.

Recent Developments

• In May 2024, Thermo Fisher launched CXCL10 testing service. It is designed for kidney transplant patients and can detect CXCL10 chemokine faster in comparison to currently used tests.

Transplant Diagnostics Market Report Scope

Global Transplant Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the transplant diagnostics market report based on test, product, application, transplant area, end use and region:

• Test Outlook (Revenue, USD Million, 2018 - 2030)

  • Molecular Assays

    • PCR-based Molecular Assays

    • Real-time PCR

    • Sequence-based Primer-PCR

    • Sequence-specific Oligonucleotide-PCR

    • Other PCR-based Molecular Assays

  • Sequencing-based Molecular Assays

    • Sanger Sequencing

    • Next Generation Sequencing

    • Other Sequencing-based Molecular Assays

  • Non-molecular Assays

    • Serological Assays

    • Mixed Lymphocyte Culture Assays

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Reagents & Consumables

  • Instruments

  • Software and Services

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diagnostic Application

    • Infectious Disease Testing

    • Histocompatibility Testing

    • Blood Profiling

  • Research Application

• Transplant Area Outlook (Revenue, USD Million, 2018 - 2030)

  • Solid Area Transplantation

    • Kidney Transplantation

    • Liver Transplantation

    • Heart Transplantation

    • Lung Transplantation

    • Pancreas Transplantation

    • Other Organs Transplantation

  • Stem Cell Transplantation

  • Soft Tissue Transplantation

  • Bone Marrow Transplantation

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals and Transplant Centers

  • Research and Academic Institutes

  • Independent Reference Laboratories

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait